SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns-Reference-Cited by-同舟云学术

SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns

Published:2022-09 Issue:9 Volume:30 Page:1231-1241.e6
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Gruell Henning,Vanshylla Kanika,Korenkov Michael,Tober-Lau Pinkus,Zehner Matthias,Münn Friederike,Janicki Hanna,Augustin Max,Schommers Philipp,Sander Leif Erik,Kurth Florian,Kreer Christoph,Klein Florian

Funder

Bundesinstitut für Arzneimittel und Medizinprodukte

Deutsche Forschungsgemeinschaft

BMBF Bonn

Universität zu Köln

Deutsches Zentrum für Infektionsforschung

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference83 articles.

1. Protection against the omicron variant from previous SARS-CoV-2 infection;Altarawneh;N. Engl. J. Med.,2022

2. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients;Andreano;Cell,2021

3. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant;Andrews;N. Engl. J. Med.,2022

4. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies;Baum;Science,2020

5. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability;Brouwer;Science,2020

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aging and viral evolution impair immunity against dominant pan-coronavirus-reactive T cell epitope;2024-08-21

2. A Cell-Based Papain-like Protease (PLpro) Activity Assay for Rapid Detection of Active SARS-CoV-2 Infections and Antivirals;2024-05-21

3. Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2;iScience;2024-05

4. Acceptance, safety, and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in patients with primary biliary cholangitis;Heliyon;2024-04

5. SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs;Cell Chemical Biology;2024-04